BSE: ZYDUSLIFE - Zydus Lifesciences Limited

Lønnsomhet i seks måneder: -8.83%
Sektor: Healthcare

Kampanjeplan Zydus Lifesciences Limited


Om selskapet

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

flere detaljer
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

ISIN INE010B01027
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
Prisendring per dag: +1.37% (959.55)
Prisendring per uke: -0.1232% (973.9)
Prisendring per måned: +2.31% (950.7)
Prisendring over 3 måneder: -9.48% (1074.6)
Prisendring over seks måneder: -8.83% (1066.95)
Prisendring per år: +41.75% (686.2)
Prisendring over 3 år: +119.03% (444.1)
Prisendring over 5 år: +332.98% (224.65)
Prisendring over 10 år: 0% (972.7)
Prisendring siden begynnelsen av året: +0.6779% (966.15)

Undervurdering

Navn Betydning Karakter
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
Total: 5

Effektivitet

Navn Betydning Karakter
ROA, % 14.03 4
ROE, % 20.67 7
Total: 4.17

Utbytte

Navn Betydning Karakter
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
Total: 2.58

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 37.72 5
Lønnsomhet Ebitda, % 36.84 5
Lønnsomhet EPS, % 233.73 10
Total: 7.2



Veileder Stillingstittel Betaling Fødselsår
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 år)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 år)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

Adresse: India, Ahmedabad, Zydus Corporate Park - åpne i Google maps, åpne Yandex-kart
Nettsted: https://zyduslife.com